Antipsychotic-induced hyperprolactinemia in Tourette syndrome
نویسندگان
چکیده
منابع مشابه
Antipsychotic-induced hyperprolactinemia.
Use of antipsychotic agents has been associated with hyperprolactinemia, or elevated prolactin levels; this hormonal abnormality can interfere with the functioning of reproductive, endocrine, and metabolic systems. As antipsychotic agents are increasingly used for both United States Food and Drug Administration-approved and nonapproved indications, many individuals are at risk for developing an...
متن کاملAntipsychotic-induced Hyperprolactinemia: Pathophysiology and Clinical Consequences
Hyperprolactinemia is one of the major adverse effects of antipsychotic agents. Although it is predominantly associated with the use of conventional or typical agents, atypical agents also cause varying degrees of hyperprolactinemia. Clinical manifestations, which tend to be underrecognized, are the result of the direct action of prolactin on its target tissues and of the sequelae of hypogonadi...
متن کاملReversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole Paraskevi Kotorki, Parthena Pelka, Christina Leotsakou, Aikaterini Kalogeropoulou, Markella Fiste, Georgios Vagionis, Anastasia Roussi, Periklis Paterakis From 1 International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance...
متن کاملCorrection: Hyperprolactinemia with antipsychotic drugs in children and adolescents
1. Reference 19 in the original article [1] (Frazier JA, et al. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry. 1999;38:960–5) was quoted as indicating that one of the 9 of 11 outpatients aged 4–17 years treated with risperidone who developed hyperprolactinemia had amenorrhea and one had gynecomastia. In fact, the only hyper...
متن کاملPotential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole.
The paper published in your journal by Migiliardi et al. (2009) reported that increased hyperprolactinemia is a major side-effect of risperidone and olanzapine treatment in children and adolescents. They showed that risperidone could cause 10 times higher prolactin levels than olanzapine treatment in children and adolescents. This was a well-designed study that controlled for dose, gender, and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapeutic Advances in Psychopharmacology
سال: 2017
ISSN: 2045-1253,2045-1261
DOI: 10.1177/2045125317705012